drugset / Trial / NCT01946399
Ozurdex Implant for Macular Edema After Treatment Failure With Anti-VEGF
Terminated
10 enrolled
Retina Research Institute, LLC
Retina-Vitreous Associates Medical Group · collabWest Coast Retina Medical Group, Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
To determine if Ozurdex implant can offer an effective treatment for macular edema associated with retinal vein occlusion when treatment with intravitreal Avastin, Lucentis, or Eylea have not demonstrated a significant response.
Timeline
- Start
- 2013-09
- Primary completion
- 2016-09-01
- Completion
- 2017-09-01
Outcome
Outcome not reported
Stopped (Enrollment): “enrollment not met”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexamethasone | Small molecule | — | Intravitreal |